Fang-hong Shi
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Evaluating the overall renal outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with chronic kidney disease (CKD).
Journal: Diabetology & metabolic syndrome
Published: August 13, 2024
Evaluating the Overall Safety of Glucokinase Activators in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: July 01, 2024
Sodium-Glucose Co-transporter 2 Inhibitors treatment improve pancreatic β-cells function and insulin resistance in patients with Type 2 diabetes.
Journal: European journal of internal medicine
Published: June 16, 2024
Breaking through diabetes management barriers: Assessing the accuracy of Freestyle Libre Pro flash continuous glucose monitoring in diabetes patients with myocardial infarction.
Journal: Digital health
Published: April 28, 2024
The Importance of Clinical Pharmacists in Improving Blood Glucose and Lipid Levels in Patients with Diabetes and Myocardial Infarction.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: June 14, 2023
Influence and mechanism of sodium-glucose cotransporter-2 inhibitors on the cardiac function: study protocol for a prospective cohort study.
Journal: Frontiers in endocrinology
Published: April 04, 2023
Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: June 24, 2022
System Dynamic Model Simulates the Growth Trend of Diabetes Mellitus in Chinese Population: Implications for Future Urban Public Health Governance.
Journal: International journal of public health
Published: May 15, 2022
Beneficial Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Left Ventricular Function.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 07, 2021
Sodium-Glucose Co-Transporter 2 Inhibitors Use Improves the Satisfaction With Anti-diabetic Agent Treatment: A Questionnaire-based Propensity Score-matched Study.
Journal: Frontiers in pharmacology
Published: October 01, 2021
Efficacy and Safety of Ertugliflozin in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Journal: Frontiers in pharmacology
Published: August 03, 2021
High-dose sodium-glucose co-transporter-2 inhibitors are superior in type 2 diabetes: A meta-analysis of randomized clinical trials.
Journal: Diabetes, obesity & metabolism
Published: January 26, 2021
Last Updated: 09/26/2026